Skip to Content
Merck
  • Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.

Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.

Journal of pharmaceutical sciences (2014-09-12)
Kayo Yuminoki, Fuko Seko, Shota Horii, Haruka Takeuchi, Katsuya Teramoto, Yuichiro Nakada, Naofumi Hashimoto
ABSTRACT

In this study, we reported the application of Povacoat®, a hydrophilic polyvinylalcohol copolymer, as a dispersion stabilizer of nanoparticles of poorly water-soluble compounds. In addition, the influence of aggregation of the nanoparticles on their solubility and oral absorption was studied. Griseofulvin (GF) was used as a model compound with poor water solubility and was milled to nanoparticles by wet bead milling. The dispersion stability of GF milled with Povacoat® or the generally used polymers (polyvinylalcohol, hydroxypropylcellulose SSL, and polyvinylpyrrolidone K30) was compared. Milled GF suspended in Povacoat® aqueous solution with D-mannitol, added to improve the disintegration rate of freeze-dried GF, exhibited high dispersion stability without aggregation (D90 = ca. 0.220 μm), whereas milled GF suspended in aqueous solutions of the other polymers aggregated (D90 > 5 μm). Milled GF with Povacoat® showed improved aqueous solubility and bioavailability compared with the other polymers. The aggregation of nanoparticles had significant impact on the solubility and bioavailability of GF. Povacoat® also prevented the aggregation of the various milled poorly water-soluble compounds (hydrochlorothiazide and tolbutamide, etc.) more effectively than the other polymers. These results showed that Povacoat® could have wide applicability to the development of nanoformulations of poorly water-soluble compounds.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5,5-Diphenylhydantoin, ≥98%
USP
Phenytoin, United States Pharmacopeia (USP) Reference Standard
Phenytoin for system suitability, European Pharmacopoeia (EP) Reference Standard
Phenytoin, European Pharmacopoeia (EP) Reference Standard
USP
Griseofulvin Permeability Diameter, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Piroxicam, ≥98% (TLC)
Sigma-Aldrich
Piroxicam, meets USP testing specifications
Supelco
Tolbutamide, analytical standard
Sigma-Aldrich
Acycloguanosine, ≥99% (HPLC), powder
Sigma-Aldrich
Naproxen, meets USP testing specifications
Sigma-Aldrich
Griseofulvin, from Penicillium griseofulvum, 97.0-102.0%
Sigma-Aldrich
Hydrochlorothiazide, crystalline
Sigma-Aldrich
Hydrochlorothiazide, meets USP testing specifications
Supelco
Phenytoin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Naproxen, VETRANAL®, analytical standard
Sigma-Aldrich
(S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid, 98%
Hydrochlorothiazide for peak identification, European Pharmacopoeia (EP) Reference Standard
Supelco
Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Hydrochlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material
Aciclovir, European Pharmacopoeia (EP) Reference Standard
USP
Acyclovir, United States Pharmacopeia (USP) Reference Standard
Naproxen, European Pharmacopoeia (EP) Reference Standard
USP
Piroxicam, United States Pharmacopeia (USP) Reference Standard
USP
Hydrochlorothiazide, United States Pharmacopeia (USP) Reference Standard
USP
Naproxen, United States Pharmacopeia (USP) Reference Standard